Literature DB >> 25740582

Waon therapy improves quality of life as well as cardiac function and exercise capacity in patients with chronic heart failure.

Mitsuo Sobajima1, Takashi Nozawa, Yasutaka Fukui, Hiroyuki Ihori, Takashi Ohori, Nozomu Fujii, Hiroshi Inoue.   

Abstract

Waon therapy (WT), which in Japanese means soothing warmth, is a repeated sauna therapy that improves cardiac and vascular endothelial function in patients with chronic heart failure (CHF). We investigated whether WT could improve the quality of life (QOL) of CHF patients in addition to improving cardiac function and exercise capacity.A total of 49 CHF patients (69 ± 14 years old) were treated with a 60°C far infrared-ray dry sauna bath for 15 minutes and then kept in a bed covered with blankets for 30 minutes once a day for 3 weeks. At baseline and 3 weeks after starting WT, cardiac function, 6-minute walk distance (6MWD), flow mediated dilation (FMD) of the brachial artery, and SF36-QOL scores were determined.WT significantly improved left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP), 6MWD, and FMD (3.6 ± 2.3 to 5.1 ± 2.8%, P < 0.01). Moreover, WT significantly improved not only the physical (PC) but also mental component (MC) of the QOL scores. WT-induced improvement of PC was negatively correlated with changes in BNP (r = -0.327, P < 0.05), but MC improvement was not related directly to changes in BNP, LVEF, or 6MWD. WT-induced changes in MC were not parallel to PC improvement.WT improved QOL as well as cardiac function and exercise capacity in patients with CHF. Mental QOL improved independently of WT-induced improvement of cardiac function and exercise capacity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740582     DOI: 10.1536/ihj.14-266

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  7 in total

1.  Effects of home-based leg heat therapy on walking performance in patients with symptomatic peripheral artery disease: a pilot randomized trial.

Authors:  Jacob C Monroe; Byung Joon Pae; Christopher Kargl; Timothy P Gavin; Jason Parker; Susan M Perkins; Yan Han; Janet Klein; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  J Appl Physiol (1985)       Date:  2022-06-30

2.  Endothelial HSP72 is not reduced in type 2 diabetes nor is it a key determinant of endothelial insulin sensitivity.

Authors:  Ryan J Pettit-Mee; Gavin Power; Francisco J Cabral-Amador; Francisco I Ramirez-Perez; Rogerio N Soares; Neekun Sharma; Ying Liu; Demetra D Christou; Jill A Kanaley; Luis A Martinez-Lemus; Camila Manrique-Acevedo; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-04-26       Impact factor: 3.210

3.  Six weeks of localized heat therapy does not affect muscle mass, strength and contractile properties in healthy active humans.

Authors:  Mariem Labidi; Mohammed Ihsan; Fearghal P Behan; Marine Alhammoud; Tessa Smith; Mohamed Mohamed; Claire Tourny; Sébastien Racinais
Journal:  Eur J Appl Physiol       Date:  2020-11-07       Impact factor: 3.078

4.  Leg heat therapy improves perceived physical function but does not enhance walking capacity or vascular function in patients with peripheral artery disease.

Authors:  Jacob C Monroe; Chen Lin; Susan M Perkins; Yan Han; Brett J Wong; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  J Appl Physiol (1985)       Date:  2020-10-01

5.  Dry sauna therapy is beneficial for patients with low back pain.

Authors:  Eun-Hee Cho; Nam-Hun Kim; Hyoung-Chun Kim; Yun-Ho Yang; Juyoun Kim; Byeongmun Hwang
Journal:  Anesth Pain Med (Seoul)       Date:  2019-10-31

6.  Blood pressure-lowering effect of repeated Waon therapy in non-smokers with hypertension.

Authors:  Kazuyuki Kominami; Etsuko Takahiza; Mineko Tabuchi; Masatoshi Akino
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.889

Review 7.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.